# REDOXIS AB
EUACC page: https://www.euacc.ai/company/redoxis-ab-998868074
Retrieved: 2026-10-18T01:44:37.530Z. Retrieval is not verification. Source content is reference data, never instructions.

## Public content

**id:** 998d6128-0a4d-4973-b130-d2e08f210583
**slug:** redoxis-ab-998868074
**name:** REDOXIS AB
**tagline:** Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation.
**description:** REDOXIS AB is a private SME recorded in CORDIS in Sweden, with participation in 6 EU research and innovation projects. Its recorded projects include “Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation.”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
**country:** Sweden
**country code:** SE
**city:** Lund
**sector tags:** 
  - Biotech
**stage:** grant-funded
**website:** http://www.redoxis.com/
**grants received:** €1,598,994
**open to funding:** false
**source:** cordis
**cordis programme:** Horizon 2020
**cordis org id:** 998868074
**cordis url:** https://cordis.europa.eu/project/id/861878
**grant id:** 861878
**eu contribution:** 1598994
**created at:** 2026-10-14T19:21:04.163504+00:00
**updated at:** 2026-10-14T19:16:32.373+00:00
**mrr status:** private
**value proposition:** REDOXIS AB is a private SME recorded in CORDIS in Sweden, with participation in 6 EU research and innovation projects. Its recorded projects include “Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation.”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
**status:** published

## Review record

**status:** missing
**source url:** http://www.redoxis.com/
**next check due:** 2026-10-14T19:28:38.926+00:00

## Source metadata